Antifungal Agents in the 1990s
- 1 April 1997
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 53 (4), 539-549
- https://doi.org/10.2165/00003495-199753040-00001
Abstract
Significant advances in antifungal therapy have occurred in the last decade. Most of these advances have been tied to the introduction of the triazoles, itraconazole and fluconazole. Itraconazole has...Keywords
This publication has 88 references indexed in Scilit:
- Management of Invasive Candidal Infections: Results of a Prospective, Randomized, Multicenter Study of Fluconazole Versus Amphotericin B and Review of the LiteratureClinical Infectious Diseases, 1996
- In vitro activity of BMS-181184 compared with those of fluconazole and amphotericin B against various candida sppAntimicrobial Agents and Chemotherapy, 1996
- Fluconazole-Induced Congenital Anomalies in Three InfantsClinical Infectious Diseases, 1996
- Old and New Therapies for SporotrichosisClinical Infectious Diseases, 1995
- In vitro evaluation of the pneumocandin antifungal agent L-733560, a new water-soluble hybrid of L-705589 and L-731373Antimicrobial Agents and Chemotherapy, 1995
- Fluconazole Combined with Flucytosine for Treatment of Cryptococcal Meningitis in Patients with AIDSClinical Infectious Diseases, 1994
- Oral Azole Drugs as Systemic Antifungal TherapyNew England Journal of Medicine, 1994
- Candidal VulvovaginitisClinical Obstetrics and Gynecology, 1993
- Treatment of cutaneous sporotrichosis with terbinafineBritish Journal of Dermatology, 1992
- Comparative Safety, Tolerance, and Pharmacokinetics of Amphotericin B Lipid Complex and Amphotericin B Desoxycholate in Healthy Male VolunteersThe Journal of Infectious Diseases, 1991